SCHEMBL8708142

SCHEMBL8708142

COc1ccc(N2C(=O)c3ccccc3C2O)cc1OC(C)CCc1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 4/20 0.51
SMN1; SMN2 Q16637 3/20 0.46
NPC1 O15118 2/20 0.46
TP53 P04637 1/20 0.46
TSHR P16473 1/20 0.46
PDE4A P27815 3/20 0.45
PDE4B Q07343 3/20 0.45
PDE4C Q08493 3/20 0.45
PDE4D Q08499 3/20 0.45
NR1H3 Q13133 2/20 0.44
NR1H2 P55055 1/20 0.44
ALDH1A1 P00352 2/20 0.43
HSD17B10 Q99714 1/20 0.43
KMT2A Q03164 2/20 0.41
QPCT Q16769 1/20 0.39
MEN1 O00255 1/20 0.38
ATM Q13315 1/20 0.38
PPARG P37231 3/20 0.37
PPARA Q07869 3/20 0.37
PPARD Q03181 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7692903 0.89 NR1H3 (0.45) RAB9ASMN1; SMN2PDE4APDE4BPDE4C
SCHEMBL8708036 0.88 QPCT (0.48) RAB9ATSHRPDE4APDE4BPDE4C
SCHEMBL8712042 0.86 NR1H3 (0.42) RAB9APDE4APDE4BPDE4CPDE4D
SCHEMBL8707308 0.82 RAB9A (0.69) RAB9ASMN1; SMN2NPC1TP53TSHR
SCHEMBL7692652 0.81 NR1H3 (0.60) PDE4APDE4BPDE4CPDE4DNR1H3
SCHEMBL7698676 0.81 LMNA (0.41) TSHRPDE4APDE4BPDE4CPDE4D
SCHEMBL7694958 0.79 NR1H3 (0.44) SMN1; SMN2PDE4APDE4BPDE4CPDE4D
SCHEMBL8713826 0.79 NR1H3 (0.52) PDE4APDE4BPDE4CPDE4DNR1H3
SCHEMBL7694754 0.79 MCHR1 (0.43) RAB9ASMN1; SMN2NPC1TP53PDE4A
SCHEMBL7701165 0.77 HTR2C (0.56) RAB9ASMN1; SMN2NPC1TP53PDE4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1998042666-A1 NOVEL 3,4-DIALKOXYPHENYL DERIVATIVES AND THE USE THEREOF DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 1998-10-01 WO disclosed
EP-0848705-A1 CRYSTALLINE R-(R*,R*)]-2-(4-FLUOROPHENYL)-BETA,DELTA-DIHYDROXY-5-(1-METHYLETHYL)-3-PHENYL-4- (PHENYLAMINO)CARBONYL]-1H-PYRROLE-1-HEPTANOIC ACID HEMI CALCIUM SALT (ATORVASTATIN) WARNER-LAMBERT COMPANY (US) 1998-06-24 EP disclosed
WO-1997003959-A1 CRYSTALLINE [R-(R*,R*)]-2-(4-FLUOROPHENYL)-BETA,DELTA-DIHYDROXY-5-(1-METHYLETHYL)-3-PHENYL-4-[(PHENYLAMINO)CARBONYL]-1H-PYRROLE-1-HEPTANOIC ACID HEMI CALCIUM SALT (ATORVASTATIN) WARNER-LAMBERT COMPANY (US) 1997-02-06 WO disclosed